抗癫痫药物对胶质瘤患者自我报告抑郁、焦虑及认知抱怨的影响
这项多中心横断面研究纳入272例胶质瘤患者,用HADS评估抑郁焦虑、MOS-CFS评估主观认知障碍。未校正时使用抗癫痫药物者抑郁患病率显著更高(21%对10%,uOR=2.29,95%CI 1.05-4.97,p=0.037),但校正混杂因素后差异不再显著(aOR=1.94,95%CI 0.83-4.50,p=0.125);焦虑与主观认知障碍在校正前后均无显著差异。结论认为抗癫痫药物使用与这些神经精神症状无独立关联。
要点
- 校正混杂因素后,抗癫痫药物使用与胶质瘤患者抑郁无独立关联(aOR=1.94,95%CI 0.83-4.50)。
- 焦虑(aOR=1.17,95%CI 0.59-2.29)与主观认知障碍(aOR=0.83,95%CI 0.34-2.04)均无显著关联。
- 其他因素对胶质瘤患者神经精神症状风险贡献更大。
核心结论
- 抗癫痫药物使用与胶质瘤患者并发抑郁、焦虑或主观认知障碍无独立关联。
- 其他因素似乎对胶质瘤患者发生神经精神症状的风险贡献更大。
研究设计与样本
- 多中心横断面研究,共纳入272例胶质瘤患者。
- 抑郁和焦虑用HADS评估,主观认知障碍用MOS-CFS评估。
- 先对全部潜在混杂预测变量做单因素logistic回归,p值<0.1者纳入多因素分析。
主要发现
- 未校正时,未用抗癫痫药物者抑郁患病率10%,使用者21%(uOR=2.29,95%CI 1.05-4.97,p=0.037)。
- 校正混杂因素后抑郁差异不再显著(aOR=1.94,95%CI 0.83-4.50,p=0.125)。
- 焦虑患病率未用药者19%、用药者26%,校正前后均无显著差异(aOR=1.17,95%CI 0.59-2.29,p=0.659)。
- 主观认知障碍患病率未用药者16%、用药者21%,校正前后均无显著差异(aOR=0.83,95%CI 0.34-2.04,p=0.684)。
临床怎么用
- 评估胶质瘤患者抑郁焦虑时,不应将抗癫痫药物使用视为独立致病因素。
- 应关注其他可干预因素对神经精神症状的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: AEDs have been associated with depression, anxiety, and cognitive impairment, all frequent complications of glioma and its subsequent treatment, with considerable morbidity and an adverse effect on health-related quality of life. This study aimed to determine the independent association between AED use and self-reported depression, anxiety, and subjective cognitive impairment in glioma patients. METHODS: In this multicenter cross-sectional study, depression and anxiety were assessed with the HADS and subjective cognitive impairment was assessed with the MOS-CFS. Univariable logistic regression analyses were performed on all potential confounding predictor variables. Potential confounders were included in the multivariable analyses if p-value < 0.1, to evaluate whether use of AEDs was independently related to depression, anxiety, and/or subjective cognitive impairment. RESULTS: A total of 272 patients were included. Prevalence of depression differed significantly between patients not using (10%) and using AEDs (21%, unadjusted Odds Ratio [uOR] = 2.29 [95%CI 1.05-4.97], p = 0.037), but after correction for confounders the statistical significant difference was no longer apparent (adjusted Odds Ratio [aOR] = 1.94 [95%CI 0.83-4.50], p = 0.125). Prevalences of anxiety (aOR = 1.17 [95%CI 0.59-2.29], p = 0.659) and subjective cognitive impairment (aOR = 0.83 [95%CI 0.34-2.04], p = 0.684) did not differ significantly before or after adjustment of confounders between patients not using (19% and 16%, respectively) and using AEDs (26% and 21%, respectively). CONCLUSIONS: Our results indicate AED use was not independently associated with concurrent depression, anxiety, or subjective cognitive impairment in glioma patients. Alternative factors seem to have a greater contribution to the risk of developing neuropsychiatric symptoms in glioma patients.
引用
- van der Meer PB, Koekkoek JAF, van den Bent MJ, et al. Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints. J Neurooncol. 2021. PMID: 33822293. doi:10.1007/s11060-021-03747-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。